post-marketing surveillance


post-·mar·ket·ing sur·veil·lance

procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc.

post-marketing surveillance

Ongoing safety monitoring—e.g., in Phase-4 and Phase-5 studies—of marketed drugs.